Skip to main content
. 2015 Feb 1;19(2):75–81. doi: 10.1089/gtmb.2014.0177

Table 3.

MTHFR C677T and RFC-1 Polymorphism Susceptibility Risks in Patients with Nephroblastoma, Their Mothers, and the Combination of Genotypes

    Nephroblastoma
    Child Mother Combineda
Polymorphism Genotypes n (%) OR (95% CI) p Controls, n (%) Case, n (%) OR (95% CI) p Controls, n Case, n OR (95% CI) p
MTHFR (C677T)
rs1801133
  CC 43 (53.7) 1 (ref)   37 (49.3) 24 (50.0) 1 (ref)   4 18 1 (ref)  
  CT 30 (37.5) 1.09 (0.64–1.88) 0.73 32 (42.7) 21 (43.7) 1.01 (0.48–2.15) 0.98
  CT+CT 4 11 0.61 (0.13–2.95) 0.54
  TT 7 (8.8) 1.24 (0.48–3.16) 0.65 6 (8.0) 3 (6.3) 0.77 (0.18–3.38) 0.73
  TT+TT 0 0 0 0
  CT/TTb 37 (46.3) 1.12 (0.68–1.86) 0.65 38 (50.7) 24 (50.0) 0.97 (0.47–2.01) 0.94
  CT/TT+CT/TT 6 18 0.67 (0.16–2.77) 0.58
RFC-1 (G80A)
rs1051266 GG 13 (17.0) 1 (ref)   30 (35.7) 15 (28.3) 1 (ref)   7 6 1 (ref)  
  GG+GA 4 5 1.46 (0.26–8.05) 0.66
  GA+GG 3 9 3.50 (0.64–19.19) 0.15
  GA 38 (49.3) 2.16 (1.07–4.33) 0.03 35 (41.7) 26 (49.0) 1.49 (0.67–3.31) 0.33
  GA+GA 5 11 2.57 (0.56–11.72) 0.22
  AA 26 (33.7) 3.53 (1.65–7.59) <0.01 19 (22.6) 12 (22.7) 1.26 (0.49–3.27) 0.63
  GA+AA 1 4 4.67 (0.40–53.95) 0.22
  AA+GA 0 9 0 0
  AA+AA 2 7 4.08 (0.60–27.65) 0.15
  GA/AAb 64 (83.0) 2.56 (1.33–4.95) <0.01 54 (64.3) 38 (71.7) 1.41 (0.67–2.97) 0.37
  GA/AA+GA/AA 8 31 4.52 (1.18–17.25) 0.03
a

Combination of child–mother genotypes.

b

CT/TT, GA/AA indicates at least one variant allele.